Consistent with the changes in FoxO1, the gene expression of G6Pase was down-regulated in the T2D mice during OA treatment (∼80%, Fig 1A), which was maintained in post-OA treatment (∼50%, both p<0.05 vs. T2D mice, Fig. 1B). Here, G6PC1 is linked to type 2 diabetes mellitus.